Goodwin Advises Indivior Pharmaceuticals on Merger With Supernus Pharmaceuticals
November 02, 2026
November 02, 2026
BOSTON, Massachusetts, Nov. 2 [Category: BizLaw/Legal] -- Goodwin, a law firm, posted the following news release:
* * *
Goodwin Advises Indivior Pharmaceuticals on Merger With Supernus Pharmaceuticals
*
The Life Sciences team guided Indivior Pharmaceuticals, Inc. ("Indivior") (Nasdaq: INDV) in its definitive agreement to combine with Supernus Pharmaceuticals, Inc. ("Supernus") (Nasdaq: SUPN) in a tax-free, all-stock merger o . . .
* * *
Goodwin Advises Indivior Pharmaceuticals on Merger With Supernus Pharmaceuticals
*
The Life Sciences team guided Indivior Pharmaceuticals, Inc. ("Indivior") (Nasdaq: INDV) in its definitive agreement to combine with Supernus Pharmaceuticals, Inc. ("Supernus") (Nasdaq: SUPN) in a tax-free, all-stock merger o . . .
